Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Nov. 12, 2025 /PRNewswire/ — Kytopen Corp., a leader in…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
